American International Group’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-37,779
Closed -$153K 258
2024
Q1
$153K Sell
37,779
-325
-0.9% -$1.31K ﹤0.01% 2296
2023
Q4
$116K Sell
38,104
-154
-0.4% -$470 ﹤0.01% 2473
2023
Q3
$115K Buy
38,258
+1,360
+4% +$4.08K ﹤0.01% 2432
2023
Q2
$138K Buy
36,898
+72
+0.2% +$269 ﹤0.01% 2384
2023
Q1
$123K Buy
36,826
+733
+2% +$2.46K ﹤0.01% 2361
2022
Q4
$174K Sell
36,093
-131
-0.4% -$630 ﹤0.01% 2202
2022
Q3
$206K Buy
36,224
+512
+1% +$2.91K ﹤0.01% 2137
2022
Q2
$254K Buy
35,712
+3,647
+11% +$25.9K ﹤0.01% 2033
2022
Q1
$232K Sell
32,065
-2,257
-7% -$16.3K ﹤0.01% 2150
2021
Q4
$307K Sell
34,322
-1,027
-3% -$9.19K ﹤0.01% 2102
2021
Q3
$1.24M Sell
35,349
-840
-2% -$29.4K 0.01% 1316
2021
Q2
$777 Buy
36,189
+27,737
+328% +$596 ﹤0.01% 1651
2021
Q1
$522 Buy
8,452
+23
+0.3% +$1 ﹤0.01% 1815
2020
Q4
$352 Buy
+8,429
New +$352 ﹤0.01% 1949